Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 14;25(8):1796.
doi: 10.3390/molecules25081796.

Selected Pharmaceuticals in Different Aquatic Compartments: Part II-Toxicity and Environmental Risk Assessment

Affiliations
Review

Selected Pharmaceuticals in Different Aquatic Compartments: Part II-Toxicity and Environmental Risk Assessment

André Pereira et al. Molecules. .

Abstract

Potential risks associated with releases of human pharmaceuticals into the environment have become an increasingly important issue in environmental health. This concern has been driven by the widespread detection of pharmaceuticals in all aquatic compartments. Therefore, 22 pharmaceuticals, 6 metabolites and transformation products, belonging to 7 therapeutic groups, were selected to perform a review on their toxicity and environmental risk assessment (ERA) in different aquatic compartments, important issues to tackle the water framework directive (WFD). The toxicity data collected reported, with the exception of anxiolytics, at least one toxicity value for concentrations below 1 µg L-1. The results obtained for the ERA revealed risk quotients (RQs) higher than 1 in all the aquatic bodies and for the three trophic levels, algae, invertebrates and fish, posing ecotoxicological pressure in all of these compartments. The therapeutic groups with higher RQs were hormones, antiepileptics, anti-inflammatories and antibiotics. Unsurprisingly, RQs values were highest in wastewaters, however, less contaminated water bodies such as groundwaters still presented maximum values up to 91,150 regarding 17α-ethinylestradiol in fish. Overall, these results present an important input for setting prioritizing measures and sustainable strategies, minimizing their impact in the aquatic environment.

Keywords: aquatic compartments; environmental contaminants; environmental risk assessment; pharmaceuticals; pharmaceuticals toxicity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Median, maximum and minimum concentration values reported for acute (A) and chronic (B) toxicity concerning algae. (Anx—anxiolytics; Antib—antibiotics; Lip reg—lipid regulators; Antiepi—antiepileptics; SSRIs—Selective serotonin reuptake inhibitors; Anti-inf—anti-inflammatories; Horm—hormones) [23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52].
Figure 2
Figure 2
Median, maximum and minimum concentration values reported for acute (A) and chronic (B) toxicity data concerning invertebrates. (Anx—anxiolytics; Antib—antibiotics; Lip reg—lipid regulators; Antiepi—antiepileptics; SSRIs—Selective serotonin reuptake inhibitors; Anti-inf—anti-inflammatories; Horm—hormones) [23,27,28,29,30,31,32,35,36,40,41,42,44,46,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84].
Figure 3
Figure 3
Median, maximum and minimum concentration values reported for acute (A) and chronic (B) toxicity data concerning fish. (Anx—anxiolytics; Antib—antibiotics; Lip reg—lipid regulators; Antiepi—antiepileptics; SSRIs—Selective serotonin reuptake inhibitors; Anti-inf—anti-inflammatories; Horm—hormones) [23,29,31,32,35,36,42,44,58,59,70,74,82,83,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137].
Figure 3
Figure 3
Median, maximum and minimum concentration values reported for acute (A) and chronic (B) toxicity data concerning fish. (Anx—anxiolytics; Antib—antibiotics; Lip reg—lipid regulators; Antiepi—antiepileptics; SSRIs—Selective serotonin reuptake inhibitors; Anti-inf—anti-inflammatories; Horm—hormones) [23,29,31,32,35,36,42,44,58,59,70,74,82,83,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137].
Figure 4
Figure 4
Median and maximum risk quotients of pharmaceuticals in WWIs for the three trophic levels. (Anx—anxiolytics; Antib—antibiotics; Lip reg—lipid regulators; Antiepi—antiepileptics; SSRIs—Selective serotonin reuptake inhibitors; Anti-inf—anti-inflammatories; Horm—hormones).
Figure 5
Figure 5
Median and maximum risk quotients of pharmaceuticals in WWEs for the three trophic levels. (Anx—anxiolytics; Antib—antibiotics; Lip reg—lipid regulators; Antiepi—antiepileptics; SSRIs—Selective serotonin reuptake inhibitors; Anti-inf—anti-inflammatories; Horm—hormones).
Figure 6
Figure 6
Median and maximum risk quotients of pharmaceuticals in surface waters for the three trophic levels. (Anx—anxiolytics; Antib—antibiotics; Lip reg—lipid regulators; Antiepi—antiepileptics; SSRIs—Selective serotonin reuptake inhibitors; Anti-inf—anti-inflammatories; Horm—hormones).
Figure 7
Figure 7
Median and maximum risk quotients of pharmaceuticals in other water bodies for the three trophic levels. (DW—drinking water; GW groundwater; SeaW—seawater; MinW—mineral water; Anx—anxiolytics; Antib—antibiotics; Lip reg—lipid regulators; Antiepi—antiepileptics; SSRIs—Selective serotonin reuptake inhibitors; Anti-inf—anti-inflammatories; Horm—hormones).

References

    1. Robles-Molina J., Lara-Ortega F.J., Gilbert-López B., García-Reyes J.F., Molina-Díaz A. Multi-residue method for the determination of over 400 priority and emerging pollutants in water and wastewater by solid-phase extraction and liquid chromatography-time-of-flight mass spectrometry. J. Chromatogr. A. 2014;1350:30–43. doi: 10.1016/j.chroma.2014.05.003. - DOI - PubMed
    1. Silva L.J.G., Lino C.M., Meisel L.M., Pena A. Selective serotonin re-uptake inhibitors (SSRIs) in the aquatic environment: An ecopharmacovigilance approach. Sci. Total Environ. 2012;437:185–195. doi: 10.1016/j.scitotenv.2012.08.021. - DOI - PubMed
    1. Gonzalez-Rey M., Bebianno M.J. Does selective serotonin reuptake inhibitor (SSRI) fluoxetine affects mussel Mytilus galloprovincialis? Environ. Pollut. 2013;173:200–209. doi: 10.1016/j.envpol.2012.10.018. - DOI - PubMed
    1. European Medicines Agency Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. European Medicines Agency; London, UK: 2006.
    1. Taylor D., Senac T. Human pharmaceutical products in the environment—The “problem” in perspective. Chemosphere. 2014;115:95–99. doi: 10.1016/j.chemosphere.2014.01.011. - DOI - PubMed

MeSH terms

Substances